Transcriptional profiling of human mesenchymal stem cells transduced with reporter genes for imaging
Tóm tắt
Mesenchymal stem cells (MSCs) can differentiate into osteogenic, adipogenic, chondrogenic, myocardial, or neural lineages when exposed to specific stimuli, making them attractive for tissue repair and regeneration. We have used reporter gene-based imaging technology to track MSC transplantation or implantation in vivo. However, the effects of lentiviral transduction with the fluc-mrfp-ttk triple-fusion vector on the transcriptional profiles of MSCs remain unknown. In this study, gene expression differences between wild-type and transduced hMSCs were evaluated using an oligonucleotide human microarray. Significance Analysis of Microarray identified differential genes with high accuracy; RT-PCR validated the microarray results. Annotation analysis showed that transduced hMSCs upregulated cell differentiation and antiapoptosis genes while downregulating cell cycle, proliferation genes. Despite transcriptional changes associated with bone and cartilage remodeling, their random pattern indicates no systematic change of crucial genes that are associated with osteogenic, adipogenic, or chondrogenic differentiation. This correlates with the experimental results that lentiviral transduction did not cause the transduced MSCs to lose their basic stem cell identity as demonstrated by osteogenic, chondrogenic, and adipogenic differentiation assays with both transduced and wild-type MSCs, although a certain degree of alterations occurred. Histological analysis demonstrated osteogenic differentiation in MSC-loaded ceramic cubes in vivo. In conclusion, transduction of reporter genes into MSCs preserved the basic properties of stem cells while enabling noninvasive imaging in living animals to study the biodistribution and other biological activities of the cells.
Từ khóa
Tài liệu tham khảo
Carter D, Tyrell A, Bubnic S, Marcelino M, Kedzierski K, Monroy R, Mills R, Danilkovitch A.Characterization of MSC potential to treat GVHD using molecular markers linked to MSC-mediated immunosuppression in vitro.Blood106: 160B–160B, 2005.
Daley GQ, Goodell MA, Snyder EY.Realistic prospects for stem cell therapeutics.Hematology Am Soc Hematol Educ Program398–418, 2003.
Johnstone B, Yoo JU.Autologous mesenchymal progenitor cells in articular cartilage repair.Clin Orthop Relat ResS156–S162, 1999.
Jundt G, Berghauser KH, Termine JD, Schulz A.Osteonectin–a differentiation marker of bone cells.Cell Tissue Res248: 409–415, 1987.
Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H.Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination.Cell Mol Neurobiol26: 1235–1252, 2006.
Sarrazin P, Hackett JA, Fortier I, Gallant MA, de Brum-Fernandes A.Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts.J Rheumatol31: 1598–1606, 2004.
Wang FJ, Anderson PW, Salem N, Kuang Y, Tennant BC, Lee Z.Gene expression studies of hepatitis virus-induced woodchuck hepatocellular carcinoma in correlation with human results.Int J Oncol30: 33–44, 2007.